| __timestamp | Celldex Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3586000 | 9757000 |
| Thursday, January 1, 2015 | 5480000 | 1253000 |
| Friday, January 1, 2016 | 6786000 | 5421000 |
| Sunday, January 1, 2017 | 12743000 | 154584000 |
| Monday, January 1, 2018 | 9538000 | 301034000 |
| Tuesday, January 1, 2019 | 3573000 | 380833000 |
| Wednesday, January 1, 2020 | 7418000 | 540099000 |
| Friday, January 1, 2021 | 4651000 | 701887000 |
| Saturday, January 1, 2022 | 2357000 | 933013000 |
| Sunday, January 1, 2023 | 6883000 | 1243336000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, revenue generation is a key indicator of a company's market position and potential for growth. Over the past decade, Sarepta Therapeutics, Inc. has consistently outperformed Celldex Therapeutics, Inc. in terms of revenue. From 2014 to 2023, Sarepta's revenue surged by an impressive 12,600%, peaking at $1.24 billion in 2023. In contrast, Celldex's revenue growth was more modest, with a peak of $12.74 million in 2017, before declining to $6.88 million in 2023.
Sarepta's strategic focus on gene therapy and rare diseases has propelled its financial success, while Celldex has faced challenges in its clinical trials and product pipeline. This revenue disparity highlights the importance of innovation and strategic direction in the biotech industry. As both companies continue to evolve, investors and industry watchers will be keenly observing their next moves.
AstraZeneca PLC and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Sarepta Therapeutics, Inc.
Breaking Down Revenue Trends: argenx SE vs Sarepta Therapeutics, Inc.
Who Generates More Revenue? argenx SE or Celldex Therapeutics, Inc.
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or ACADIA Pharmaceuticals Inc.?
Sarepta Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?
Revenue Showdown: ADMA Biologics, Inc. vs Celldex Therapeutics, Inc.
PTC Therapeutics, Inc. or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Perrigo Company plc vs Celldex Therapeutics, Inc.
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.?